Skip to main content
FrameworkMapper
CIS Controls NIST CSF v2 HIPAA (clinical) FDA-aligned

Cybersecurity Compliance for Pharmaceuticals

Protect clinical trial data, intellectual property, and manufacturing systems. FrameworkMapper maps your security stack against CIS Controls and NIST CSF v2 β€” aligned with FDA cybersecurity guidance for drug manufacturers and clinical operations.

Already have an account? Sign in

Why This Matters

Pharma Is a Nation-State Target

Drug formulas, clinical trial data, and manufacturing systems are among the highest-value targets for sophisticated threat actors.

πŸ’Š
IP Theft

Pharmaceutical IP theft is among the most costly cybercrimes β€” drug formulas and clinical trial data are high-value targets for nation-state actors

Intelligence community assessment

🏭
21 CFR

FDA has issued cybersecurity guidance for drug manufacturing (21 CFR Part 11) and medical device security

FDA regulatory guidance

πŸ₯
HIPAA

Pharma companies operating clinical sites are HIPAA covered entities or business associates β€” requiring HIPAA Security Rule compliance

HHS regulatory requirement

πŸ”¬
Supply Chain

Supply chain attacks on pharmaceutical manufacturers can disrupt drug production and patient care

Industry risk analysis

Recommended Frameworks

What Pharmaceutical Organizations Should Be Using

FrameworkMapper supports all frameworks below, with pharma-tuned prioritization built in.

Framework Why It Applies Status
CIS Controls v8.1 Practical safeguards for both IT and OT/manufacturing environments Strongly Recommended
NIST CSF v2 Core risk management framework aligned with FDA cybersecurity expectations Strongly Recommended
HIPAA Security Rule Required for pharma organizations operating clinical sites or handling patient health information Mandatory (if clinical operations)
NIST SP 800-53 Applicable for pharma organizations working with government health agencies (NIH, DoD) Conditional

How FrameworkMapper Helps

Tools Built for Complex Pharma Environments

πŸ—ΊοΈ

Map IT, OT, and Clinical System Security

Visualize how your security tools address CIS Controls across research, manufacturing, and clinical environments β€” a critical first step for FDA-aligned security programs.

Launch Aggregator
πŸ”

Find Pharmaceutical-Grade Security Solutions

ToolMapper surfaces tools relevant for pharma environments including OT/ICS security solutions, clinical data protection, and IP security.

Launch ToolMapper
πŸ“Š

Generate Documentation for FDA and Audit Requirements

CIS and NIST CSF assessments produce reports that support FDA 21 CFR Part 11 compliance documentation and clinical audit requirements.

View Assessments
UCPA Β· SLTT Proxy Profile V06

Pharmaceuticals Priority Scoring Weights

The Universal Control Prioritization Algorithm uses seven factors, each weighted to reflect the regulatory intensity, IP protection requirements, and threat environment of pharmaceutical organizations. The emphasis shown is qualitative β€” the exact factor coefficients are part of the licensed UCPA methodology and aren't published.

Pharmaceuticals uses the SLTT (V06) weight profile as a proxy β€” heavily regulated environments with significant IP and clinical data obligations. A dedicated Pharmaceuticals profile is on the FrameworkMapper roadmap.

Factor Emphasis What This Means
T Threat Relevance Leads Controls targeting nation-state IP theft, ransomware on manufacturing systems, and clinical data threats score higher
D Dependency Score Moderate Foundation controls that enable others are prioritized across IT, OT, and clinical environments
E Effort-to-Value Moderate High-impact controls relative to implementation effort surface first in the remediation roadmap
B Blast Radius Moderate Controls preventing manufacturing shutdowns or large-scale clinical data exposure receive a boost
R Regulatory Criticality Leads Highest weight β€” controls tied to FDA 21 CFR Part 11, HIPAA, and NIH/DoD requirements are prioritized first
C Coverage Breadth Moderate Controls addressing multiple attack vectors across IT, OT, and clinical domains are prioritized
A Asset Exposure Light Controls protecting IP, clinical trial data, and manufacturing systems weighted accordingly

Regulatory Criticality and Threat Relevance share the highest weighting β€” FDA requirements and nation-state IP theft threats both demand that compliance-critical and threat-mitigating controls be addressed first.

Read the Full UCPA Methodology See the Pharmaceuticals Sample Assessment
Tool Trust Index · Vertical Profile V04

Pharmaceuticals Tool Trust Profile

Tools recommended for Pharmaceuticals are scored against this signal profile. Customers may toggle the ○ signals on within their account; KEV cannot be disabled.

Signal Defaults

on available n/a
KEV
MA
FedRAMP
GovRAMP
FIPS
CSA
4
Signals on by default

Signal point values and vertical weights are part of the scored methodology and aren't published.

Pharma procurement reflects FDA 21 CFR Part 11, GxP, and pharmacovigilance compliance. FedRAMP is available but off by default β€” relevant for FDA-facing or federally-funded tooling. CSA STAR is default ON given the cloud-heavy pharma R&D and supply-chain stack.

Read the Full Tool Trust Index

Threat-Informed Defense

Know Your Adversaries

Compliance tells you which controls to implement. FrameworkMapper's threat layer tells you who is actually attacking organizations like yours β€” and what they can still do.

Prefer to work with a partner?

MSSPs and consultancies on FrameworkMapper run assessments and remediation programs for organizations like yours β€” or bring your existing provider and link them to your account.

About the Partner Program β†’

Ready to assess your organization's security posture?

Start with the Coverage Aggregator β€” free with your FrameworkMapper account β€” or run a full CIS Controls or NIST CSF assessment tailored for pharmaceutical and clinical environments.

Already have an account? Sign in